Breast Cancer Trial, Recruiting (NCT06400563)

Breast Cancer Trial, Recruiting NCT06400563 Sponsor: Keith D. Paulsen Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06400563 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women aged 18 years or older
People who are able to provide written consent to participate
Women who have recently been diagnosed with breast cancer
Women who are in the planning stage before surgery and whose tumor is estimated to be 2.0 cm or smaller based on available scans
Women who are in the planning stage before surgery and who had a breast biopsy at least 10 days before the special scan used in this trial

Who may not be able to join:

People who have a reason they cannot safely have an MRI scan, including having an electronic implant such as a pacemaker, having a metal implant such as an aneurysm clip, having claustrophobia (fear of enclosed spaces), or having kidney failure severe enough that the contrast dye used in MRI scans is considered unsafe by FDA guidance (confirm with trial site)
Women who are pregnant
Women who have breast implants
People who are currently imprisoned
People whose breast biopsy site has not healed well enough to be visually acceptable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Keith D. Paulsen, PhD, Dartmouth College

Phone: 603-646-2695

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06400563

Sponsor: Keith D. Paulsen

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 603-646-2695

More information: https://clinicaltrials.gov/study/NCT06400563

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women aged 18 years or older
People who are able to provide written consent to participate
Women who have recently been diagnosed with breast cancer
Women who are in the planning stage before surgery and whose tumor is estimated to be 2.0 cm or smaller based on available scans
Women who are in the planning stage before surgery and who had a breast biopsy at least 10 days before the special scan used in this trial

Who may not be able to join:

People who have a reason they cannot safely have an MRI scan, including having an electronic implant such as a pacemaker, having a metal implant such as an aneurysm clip, having claustrophobia (fear of enclosed spaces), or having kidney failure severe enough that the contrast dye used in MRI scans is considered unsafe by FDA guidance (confirm with trial site)
Women who are pregnant
Women who have breast implants
People who are currently imprisoned
People whose breast biopsy site has not healed well enough to be visually acceptable

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Keith D. Paulsen

Registry

ClinicalTrials.gov

Start date

25 November 2024

Est. completion

1 July 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Optical sensitivity of the MRg-NIRS platform

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov